<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>Fetuin-A is a glycoprotein which helps in the regulation of metabolism. It is an early marker of insulin resistance (IR). The aim of this study was to evaluate the role of Fetuin-A as a predictive biomarker in cases of newly detected type 2 diabetes (NDD). The study involved 60 NDD and 60 Normal Healthy Controls (NHC). All the demographics and anthropological characteristics were noted. Fasting blood samples were drawn and various biochemical parameters were analyzed. The homeostatic model assessment of insulin resistance (HOMA-IR) and the quantitative insulin sensitivity check index (QUICKI) score was calculated. Chisquare, student T-test and Mann Whitney U tests were employed to associate and compare the mean and median between the NDD and NHC groups. Pearson's and Spearman’s correlation analysis were employed to examine the relationship of Fetuin-A levels with parametric and nonparametric variables. The independent predictors of Fetuin-A was determined by employing multiple forward linear regression. Fetuin-A was significantly high in NDD compared to NHC (1323 vs. 306.98 mcg/mL; p&lt;0.001). Majority of NDD patients demonstrated IR based on the HOMA-IR (88.33% vs. 66.67%) and QUICKI score (96.67% vs. 85%). The multiple linear regression analysis showed that systolic blood pressure, age and QUICKI score were independently associated with Fetuin-A (p value &lt;0.01). Fetuin-A may be used as a biomarker to detect NDD. Therefore, early detection of Fetuin-A levels in NDD gives an opportunity for suitable patient management.</p>
</abstract>

Fetuin-A is a glycoprotein which helps in the regulation of metabolism. It is an early marker of insulin resistance (IR). The aim of this study was to evaluate the role of Fetuin-A as a predictive biomarker in cases of newly detected type 2 diabetes (NDD). The study involved 60 NDD and 60 Normal Healthy Controls (NHC). All the demographics and anthropological characteristics were noted. Fasting blood samples were drawn and various biochemical parameters were analyzed. The homeostatic model assessment of insulin resistance (HOMA-IR) and the quantitative insulin sensitivity check index (QUICKI) score was calculated. Chisquare, student T-test and Mann Whitney U tests were employed to associate and compare the mean and median between the NDD and NHC groups. Pearson's and Spearman’s correlation analysis were employed to examine the relationship of Fetuin-A levels with parametric and nonparametric variables. The independent predictors of Fetuin-A was determined by employing multiple forward linear regression. Fetuin-A was significantly high in NDD compared to NHC (1323 vs. 306.98 mcg/mL; p<0.001). Majority of NDD patients demonstrated IR based on the HOMA-IR (88.33% vs. 66.67%) and QUICKI score (96.67% vs. 85%). The multiple linear regression analysis showed that systolic blood pressure, age and QUICKI score were independently associated with Fetuin-A (p value <0.01). Fetuin-A may be used as a biomarker to detect NDD. Therefore, early detection of Fetuin-A levels in NDD gives an opportunity for suitable patient management.

Fetuin-A as a Marker of Insulin Resistance

Experimental and Applied Biomedical Research (EABR)

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

{"article-title":"Fetuin-A as a Marker of Insulin Resistance"}

Fetuin-A is a glycoprotein which helps in the regulation of metabolism. It is an early marker of insulin resistance (IR). The aim of this study was to evaluate...

Fetuin-A as a Marker of Insulin Resistance

Publié en ligne: 02 janv. 2024

Pages: 289 - 295

Reçu: 09 déc. 2020

Accepté: 03 avr. 2021

DOI: https://doi.org/10.2478/sjecr-2021-0042

Mots clés
Alpha-2-HS-Glycoprotein, biomarkers, endocrinology, insulin resistance, type 2 diabetes mellitus

© 2021 Ganavi P Yamasandhi et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Fetuin-A as a Marker of Insulin Resistance

Publié en ligne: 02 janv. 2024

Pages: 289 - 295

Reçu: 09 déc. 2020

Accepté: 03 avr. 2021

DOI: https://doi.org/10.2478/sjecr-2021-0042

Mots clésAlpha-2-HS-Glycoprotein, biomarkers, endocrinology, insulin resistance, type 2 diabetes mellitus

© 2021 Ganavi P Yamasandhi et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mots clés
Alpha-2-HS-Glycoprotein, biomarkers, endocrinology, insulin resistance, type 2 diabetes mellitus